Long-Term Safety of Elagolix With Hormonal Add-Back Therapy in Women With Endometriosis-Associated Pain: 24-Month Results

被引：0
|
作者：
Simon, James [1 ]
Kim, Jin Hee [1 ]
Thomas, James [1 ]
Miller, Paul [1 ]
Snabes, Michael [1 ]
机构：
[1] IntimMedicine Specialists, Washington, DC USA
来源：
OBSTETRICS AND GYNECOLOGY | 2022年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
A86
引用
收藏
页码：25S / 26S
页数：2
相关论文
共 50 条
  • [31] Evaluation of Relugolix Combination Therapy and Bone Mass in Women with Endometriosis-associated Pain Through 52 Weeks: SPIRIT Long-Term Extension Study
    McClung, Michael R.
    Santora, Arthur
    Johnson, Neil
    Cummings, Steve R.
    Wang, Furong
    Wagman, Rachel B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 17 - 18
  • [32] Evaluation of Relugolix Combination Therapy and Bone Mass in Women with Endometriosis-associated Pain Through 52 Weeks: SPIRIT Long-Term Extension Study
    McClung, Michael R.
    Santora, Arthur
    Johnson, Neil
    Cummings, Steve R.
    Wang, Furong
    Wagman, Rachel B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 249 - 250
  • [33] Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis
    Ali, Mustafa
    Hira, Aruna Kumari
    Jawaid, Haris
    Zakaria, Faiza
    Somjee, Zehra
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2021, 26 (01)
  • [34] Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain
    Caruso, Salvatore
    Iraci, Marco
    Cianci, Stefano
    Vitale, Salvatore Giovanni
    Fava, Valentina
    Cianci, Antonio
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 2371 - 2378
  • [35] Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis
    Mustafa Ali
    Aruna Kumari Hira
    Haris Jawaid
    Faiza Zakaria
    Zehra Somjee
    Middle East Fertility Society Journal, 26
  • [36] Bone Mineral Density After 48 Months of Elagolix plus Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids.
    Schnell, Vicki L.
    Simon, James
    Brown, Eric
    Bredeson, Liesl
    Thomas, James
    Chan, Anna
    Snabes, Michael C.
    REPRODUCTIVE SCIENCES, 2024, 31 : 109A - 109A
  • [37] LONG-TERM GONADOTROPIN-RELEASING-HORMONE AGONIST THERAPY - THE EVOLVING ISSUE OF STEROIDAL ADD-BACK PARADIGMS
    ADASHI, EY
    HUMAN REPRODUCTION, 1994, 9 (07) : 1380 - 1397
  • [38] Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain
    Al-Azemi, M.
    Jones, G.
    Sirkeci, F.
    Walters, S.
    Houdmont, M.
    Ledger, W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (12) : 1646 - 1656
  • [39] Long-term treatment of endometriosis-related pain among women seeking hormonal contraception
    Vannuccini, Silvia
    Biagiotti, Chiara
    Esposto, Maria Celeste
    La Torre, Francesco
    Clemenza, Sara
    Orlandi, Gretha
    Capezzuoli, Tommaso
    Petraglia, Felice
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (05) : 398 - 402
  • [40] A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding
    Wang, Xianying
    Li, Jingxin
    Liu, Yang
    Zheng, Yingying
    Wang, Xiaoli
    Liu, Guoqiang
    GLAND SURGERY, 2025, 14 (01)
12345